OA10402A - Spirostanyl glycosidal crystals - Google Patents

Spirostanyl glycosidal crystals Download PDF

Info

Publication number
OA10402A
OA10402A OA60970A OA60970A OA10402A OA 10402 A OA10402 A OA 10402A OA 60970 A OA60970 A OA 60970A OA 60970 A OA60970 A OA 60970A OA 10402 A OA10402 A OA 10402A
Authority
OA
OAPI
Prior art keywords
crystalline
spirostan
oxy
glycoside
bis
Prior art date
Application number
OA60970A
Other languages
English (en)
Inventor
J Douglas Allen
Richard A Buzon Sr
Michael P Deninno
Harry A Watson Jr
Jonathan B Zung
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10402A publication Critical patent/OA10402A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA60970A 1994-08-30 1997-02-28 Spirostanyl glycosidal crystals OA10402A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29810694A 1994-08-30 1994-08-30

Publications (1)

Publication Number Publication Date
OA10402A true OA10402A (en) 2001-12-05

Family

ID=23149057

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60970A OA10402A (en) 1994-08-30 1997-02-28 Spirostanyl glycosidal crystals

Country Status (20)

Country Link
US (1) US5804562A (es)
EP (1) EP0778846A1 (es)
JP (1) JPH09510735A (es)
KR (1) KR970705574A (es)
AU (1) AU2265395A (es)
BR (1) BR9503827A (es)
CA (1) CA2198097A1 (es)
CO (1) CO4480032A1 (es)
FI (1) FI970828A (es)
HR (1) HRP950459A2 (es)
IL (1) IL115062A0 (es)
MA (1) MA23651A1 (es)
MX (1) MX9701525A (es)
NO (1) NO970910L (es)
OA (1) OA10402A (es)
PE (1) PE47696A1 (es)
PL (1) PL318937A1 (es)
SI (1) SI9520092A (es)
TR (1) TR199501065A2 (es)
WO (1) WO1996006854A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU94046294A (ru) * 1992-06-26 1996-10-10 Пфайзер Инк. (US) Стероидные гликозиды для лечения гиперхолестеринэмии
US5698526A (en) * 1993-12-28 1997-12-16 Pfizer Inc. Steroidal glycosides

Also Published As

Publication number Publication date
KR970705574A (ko) 1997-10-09
NO970910D0 (no) 1997-02-27
AU2265395A (en) 1996-03-22
US5804562A (en) 1998-09-08
CA2198097A1 (en) 1996-03-07
SI9520092A (en) 1997-12-31
WO1996006854A1 (en) 1996-03-07
PL318937A1 (en) 1997-07-21
PE47696A1 (es) 1996-11-12
HRP950459A2 (en) 1997-08-31
FI970828A0 (fi) 1997-02-27
JPH09510735A (ja) 1997-10-28
MA23651A1 (fr) 1996-04-01
BR9503827A (pt) 1996-09-10
CO4480032A1 (es) 1997-07-09
FI970828A (fi) 1997-02-27
TR199501065A2 (tr) 1996-06-21
NO970910L (no) 1997-02-27
EP0778846A1 (en) 1997-06-18
IL115062A0 (en) 1995-12-08
MX9701525A (es) 1997-05-31

Similar Documents

Publication Publication Date Title
US5703052A (en) Sterodial glycosides for treating hypercholesterolemia
GB2033747A (en) Method and composition for treating psoriases with retinoyl compounds
US5760009A (en) Spirostanyl glycosidal crystalline monohydrate
OA10402A (en) Spirostanyl glycosidal crystals
US6150336A (en) Steroidal glycosides
CA2180148A1 (en) Hypocholesterolemic agents
CA1251784A (en) Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments
CA1114385A (en) N-(mercaptoacyl)-histidine
US3845085A (en) Steroids of the pregnane series
CA1255293A (en) 2-oxa- or -aza-pregnane compounds
EP0320253B1 (en) 21-alkoxysteroid compounds
CA1058610A (en) 17a, 21-diesters of the pregnane series
NZ200779A (en) 4-alpha,5-alpha-epoxy-3,20-dioxopregnane-2-alpha
US4127589A (en) 4,5-Seco-steroids
CN114213494A (zh) 帕拉米松乙酸酯及帕拉米松的制备方法
NO945001L (no) Steroide glykosider for behandling av hyperkolestrolemi
JPH01316397A (ja) １１β，１７α，２１―トリヒドロキシ―１，４―プレグナジエン―３，２０―ジオン　２１―〔（Ｅ，Ｅ）―３，７，１１―トリメチル―２，６，１０―ドデカトリエノアート〕及びこれを含有する抗炎症剤